Ardelyx appoints new Chief Business and HR Officers to drive growth and innovation

From Yahoo Finance: 2025-06-29 03:03:00

Ardelyx, Inc. (NASDAQ: ARDX) makes key leadership changes, promoting Mike Kelliher to Chief Business Officer and hiring James P. Brady as Chief Human Resources Officer. CEO Mike Raab emphasizes their roles in advancing commercial and clinical programs.

Ardelyx specializes in gastrointestinal and kidney disease medicines like IBSRELA and XPHOZAH. The company serves adult patients in the U.S. and globally, aiming to deliver impactful treatments. The recent leadership appointments are part of a strategy to drive growth and innovation.

CEO Mike Raab praises Mike Kelliher’s business acumen and leadership qualities, while highlighting James P. Brady’s HR expertise. Their contributions are expected to accelerate key business initiatives and talent strategies, driving Ardelyx’s mission forward.

Investors considering Ardelyx (ARDX) should also explore potentially undervalued AI stocks with significant growth potential. For insights on a promising AI stock poised to benefit from current economic trends, check out a free report on the best short-term AI investment opportunities.



Read more at Yahoo Finance: Ardelyx (ARDX) Appoints New Chief Business and HR Officers